Tech Company Financing Transactions
Octave Bioscience Funding Round
On 7/26/2023, Octave Bioscience secured $30 million in Series B financing from dRx Capital, Hikma Ventures and Blue Venture Funds.
Transaction Overview
dRx Capital (Lead Investor)
Hikma Ventures (Lead Investor)
Deerfield Capital (Julian Harris)
Echo Health Ventures (Kurt Sheline)
Merck Global Health Innovation Fund (David Rubin)
Northpond Ventures (Michael Rubin)
Section 32 (Michael Pellini)
Company Information
Menlo Park, CA 94025
USA
Management Team
Browse more venture capital transactions:
Prev: 7/26/2023: Collaborative Robotics venture capital transaction
Next: 7/26/2023: Electra Aero venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs